Hong Xin
Senior Director, Oncology Scientific Innovation Johnson & Johnson
Hong Xin, Ph.D., is Senior Director, External Innovation Search & Evaluation, Eastern US at Johnson & Johnson Innovation – Boston Innovation Center, where she develops early-stage innovation pipelines aligned with the Janssen oncology franchise. She previously implemented strategy for the Asia-Pacific Innovation Center in Korea and spent over a decade in drug discovery within Janssen R&D, gaining deep expertise across therapeutic areas and emerging platform technologies. Her work focuses on sourcing and advancing transformative science toward novel therapeutic development.
Seminars
Tuesday 15th September 2026
Pharma & Investor Roundtable Discussions
2:00 pm
- Connect directly with leading experts in an interactive roundtable setting, sharing your work and showcasing your assets in focused, face-to-face conversations
- For pharma and investors, engage with senior leaders from pioneering biotech and academics early to uncover opportunities for collaboration
- For biotech, gain actionable insights by hearing what your peers are developing and understand first-hand the direction of pharma and biotech innovation
- Leave with new connections, strategic alignment opportunities, and practical knowledge to advance your projects
Tuesday 15th September 2026
Panel Discussion: Aligning Pharma Partnership Expectations Across Biotech & Academics to Encourage Successful Collaborations
1:30 pm
- Identifying the ideal development stage for engagement to ensure timely and effective collaboration
- Detailing therapies of interest, considering in vivo and beyond to identify high-value opportunities
- Discussing collaboration processes beyond initial interest to secure
